News
MND Association acts on tofersen decision
21 March 2024
Tofersen is a proven, effective treatment. Clinical trials have shown it slows progression of MND in people who have the SOD1 gene alteration.
News
New research partnership to support the search for MND treatments
19 March 2024
Researchers at the University of Nottingham are joining forces with Stand Against MND, the charity co-founded by Sam Perkins who has MND, and the MND Association, to carry out research
News
Statement in response to NICE decision regarding tofersen
13 March 2024
Last week we heard the disappointing news that NICE has confirmed its decision to appraise the drug tofersen through the Single Technology Appraisal (STA) route